Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
21.18
-0.24 (-1.12%)
At close: Feb 27, 2026, 4:00 PM EST
21.35
+0.17 (0.80%)
After-hours: Feb 27, 2026, 6:00 PM EST
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.31 billion as of February 27, 2026. Its market cap has increased by 10.38% in one year.
Market Cap
3.31B
Enterprise Value
2.37B
1-Year Change
10.38%
Ranking
Category
Stock Price
$21.18
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.31B, an increase of 75.26%. That is a compound annual growth rate of 7.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.36B | 38.72% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 3.80B |
| ADMA Biologics | 3.71B |
| Alumis | 3.70B |
| Legend Biotech | 3.51B |
| Xenon Pharmaceuticals | 3.46B |
| Spyre Therapeutics | 3.38B |
| Arcutis Biotherapeutics | 3.35B |
| Edgewise Therapeutics | 3.22B |